Free Trial
NYSEAMERICAN:PHGE

BiomX (PHGE) Stock Price, News & Analysis

$0.30
-0.03 (-9.23%)
(As of 07/19/2024 ET)
Today's Range
$0.28
$0.35
50-Day Range
N/A
52-Week Range
$0.19
$0.86
Volume
192,592 shs
Average Volume
97,735 shs
Market Capitalization
$20.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

BiomX MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
578.0% Upside
$2.00 Price Target
Short Interest
Bearish
1.52% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.52) to ($0.25) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.42 out of 5 stars

PHGE stock logo

About BiomX Stock (NYSEAMERICAN:PHGE)

BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

PHGE Stock Price History

PHGE Stock News Headlines

Own NVDA? Prepare for a “cash avalanche”
The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the start of the year.
BiomX’s Strategic Progress and Positive Trials Fuel Buy Rating
BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript
Own NVDA? Prepare for a “cash avalanche”
The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the start of the year.
See More Headlines
Receive PHGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/20/2024
Today
7/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:PHGE
CIK
N/A
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$2.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+578.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-26,170,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.07 per share

Miscellaneous

Free Float
67,705,000
Market Cap
$20.59 million
Optionable
N/A
Beta
1.32
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Jonathan Eitan Solomon MBA (Age 47)
    CEO & Director
    Comp: $528.57k
  • Ms. Marina Wolfson CPA (Age 40)
    CFO & Secretary
    Comp: $279.42k
  • Dr. Merav Bassan Ph.D. (Age 58)
    Chief Development Officer
    Comp: $356.59k
  • Prof. Rotem Sorek Ph.D.
    Scientific Founder
  • Dr. Eran Elinav M.D.
    Ph.D., Scientific Founder
  • Dr. Timothy K. Lu M.D. (Age 43)
    Ph.D., Scientific Founder
  • Ms. Inbal Benjamini-Elran
    C.H.R.O
  • Mr. Assaf Oron (Age 50)
    Chief Business Officer
    Comp: $352.04k

PHGE Stock Analysis - Frequently Asked Questions

How were BiomX's earnings last quarter?

BiomX Inc. (NYSEAMERICAN:PHGE) posted its earnings results on Monday, May, 20th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.07) by $0.08.

How do I buy shares of BiomX?

Shares of PHGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:PHGE) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners